SIMPLEX TRADING, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2022$487,000
+1523.3%
48,092
+1308.3%
0.00%
Q2 2022$30,000
-62.5%
3,415
-59.4%
0.00%
Q1 2022$80,000
-68.5%
8,401
-63.6%
0.00%
Q4 2021$254,000
+2016.7%
23,065
+2613.5%
0.00%
Q3 2021$12,000
+20.0%
850
+13.3%
0.00%
Q2 2021$10,000750
+4900.0%
0.00%
Q4 2020$0
-100.0%
15
-98.6%
0.00%
Q2 2020$23,000
-86.7%
1,103
-83.5%
0.00%
Q4 2019$173,000
+76.5%
6,689
+32.6%
0.00%
Q3 2019$98,000
+55.6%
5,043
+30.3%
0.00%
Q2 2019$63,0003,871
+64416.7%
0.00%
Q1 2019$0
-100.0%
6
-96.2%
0.00%
Q4 2018$4,000
+300.0%
157
+324.3%
0.00%
Q3 2018$1,000
-93.8%
37
-94.8%
0.00%
Q2 2018$16,000709
+2115.6%
0.00%
Q1 2018$0
-100.0%
32
-97.3%
0.00%
-100.0%
Q3 2017$40,000
-71.4%
1,177
-66.7%
0.00%
-66.7%
Q2 2017$140,000
+382.8%
3,538
+329.4%
0.01%
+200.0%
Q3 2016$29,000
+262.5%
824
+129.5%
0.00%
+100.0%
Q2 2016$8,000359
+11866.7%
0.00%
Q1 2016$030.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,269,584$69,497,223,00012.98%
Newtyn Management, LLC 1,375,000$13,145,0003.15%
Chescapmanager LLC 1,166,574$11,152,0001.51%
Baupost Group 13,643,333$130,430,0001.40%
Weiss Asset Management LP 5,412,487$51,743,0001.07%
CM Management, LLC 120,000$1,147,0000.96%
Orbimed Advisors 3,254,713$31,115,0000.50%
King Wealth Management Group 122,000$1,166,0000.23%
Woodline Partners LP 1,326,653$12,683,0000.21%
PDT Partners, LLC 192,701$1,842,0000.16%
View complete list of THERAVANCE BIOPHARMA INC shareholders